Cell Harvesting Systems Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report, the Cell Harvesting Systems Market is estimated to be USD 3.34 billion in 2017 and predicted to rise to USD 6.35 billion by 2022 with a CAGR of 13.7%. The market is segmented by Application (Bone Marrow, Umbilical Cord, Adipose Tissue, Peripheral Blood), by End-user (Academic Institutes, Hospitals, Diagnostic Labs, Research Centers), by Techniques (Blastomere Extraction, Altered Nuclear Transfer). The market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
Cell harvesting is a technique where stem cells are utilized in regeneration and transplanting the damaged organs with healthy ones. Cell harvesting technique is expected to lead in the future of biopharmaceutical industry with a wide scope ranging from the regeneration of skin in burn victims to treating cancers.
The increasing demand for cell regeneration as a treatment for chronic conditions is a key driver behind the growth of the Cell Harvesting market. Other factors like increasing stem cell transplantation rate and rising investment in stem cell research also have a positive impact on the growth of the Cell Harvesting market. However, the cumbersomeness of the treatment, complications arising during the cell harvesting, high cost, and subsequent lack of sufficient reimbursement policies prove to be restraining the growth of the market.
The market is segmented by application, by end-user, and by the technique. According to type, the market is sub-segmented into Bone Marrow, Umbilical Cord, Adipose Tissue and Peripheral Blood. The application segment is dominated by Peripheral Blood and is forecast to maintain its dominance in the years to come. Under end-user, the market of further categorized into Academic Institutes, Hospitals, Diagnostic Labs and Research Institutes. Because a major part of cell harvesting for stem cell regeneration is done in hospitals, hospitals lead the end-use segment of the market and are expected to retain its top position in the forecast period. The growth of stem cell harvesting in academic institutes is also estimated to be fuelled by the rise in research on cell harvesting. By technique, the market is further classified into Blastomere Extraction and Altered Nuclear Transfer.
The market is also segmented geographically into Asia Pacific, Europe, Middle East & Africa, Latin America and North America. Given the higher rate of stem cell research and transplantation, North America and Europe dominate the market. Increase in prevalence of cancer and the rise in aging population also propels the market growth in these areas.
The leading players in the current market are Avita Medical; Tomtec; Terumo Corporation; Perkin Elmer, Inc; Argos Technologies, Inc; Bertin, Arthrex, Inc and Brand GmBh + CO KG.
Browse through the full report at “https://www.marketdataforecast.com/market-reports/cell-harvesting-systems-market-8158/” and checkout our recent reports in the Health care category at “https://www.marketdataforecast.com/category/healthcare-1/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.